132 S. 10th Street
Main Building, Suite 280
Philadelphia, PA 19107
(215) 955-2071
Main Building, Suite 280
Philadelphia, PA 19107
(215) 955-2071
Most Recent Peer-reviewed Publications
- Thoracic myelopathy due to an intramedullary herniated nucleus pulposus: First case report and review of the literature
- Pilomatrix carcinoma of the thoracic spine: Case report and review of the literature
- Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma
- Mechanisms of primary axonal damage in a viral model of multiple sclerosis
- Revisiting anaplastic astrocytomas I: An expansive growth pattern is associated with a better prognosis
- Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus
- Characterization of the null murine sodium/myo-inositol cotransporter 1 (Smit1 or Slc5a3) phenotype: Myo-inositol rescue is independent of expression of its cognate mitochondrial ribosomal protein subunit 6 (Mrps6) gene and of phosphatidylinositol levels in neonatal brain
- Curvularia fungi presenting as a large cranial base meningioma: Case report
- Rosai-Dorfman disease of the colon
- Demyelinating and nondemyelinating strains of mouse hepatitis virus differ in their neural cell tropism
- Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells
- Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas
- Characterization of the chicken inward rectifier K+ channel IRK1/Kir2.1 gene.
- Characterization of the chicken inward rectifier K+ channel IRKI/Kir2.I gene
- Gliosarcoma arising from an anaplastic ependymoma: A case report of a rare entity
- Inclusion body myositis in connective tissue disorders: Case report and review of the literature
- Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade
- Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomas
- Expression of constitutively activated EGFRvIII in non-small cell lung cancer
- Constitutively active forms of c-Jun NH 2-terminal kinase are expressed in primary glial tumors